Full press release can be read here. They own Words+, Inc. and FutureLab(TM), which are based on its proprietary software technologies and this is software used by the biotech and phama industry and has to do with metabolism of enzymes. BD
NEW YORK (GenomeWeb News) - Simulations Plus said on Friday that the US Food and Drug Administration has licensed its ADMET Predictor software for use in its Cardiovascular and Renal Products division. ADMET Predictor predicts approximately 80 properties of molecules, including physicochemical, biopharmaceutical, metabolism, toxicity, and some activity properties, based on their molecular structure.
GenomeWeb News: FDA Licenses ADMET Predictor from Simulations Plus
0 comments :
Post a Comment